{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:07:03Z","timestamp":1791072423409,"version":"4.1.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.vaccine.2007.12.007","type":"journal-article","created":{"date-parts":[[2008,2,2]],"date-time":"2008-02-02T12:24:01Z","timestamp":1201955041000},"page":"1011-1024","source":"Crossref","is-referenced-by-count":156,"title":["Vaccines and immunotherapy against Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"26","author":[{"given":"Gerd","family":"D\u00f6ring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald B.","family":"Pier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.12.007_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00003495-200767030-00003","article-title":"The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections","volume":"67","author":"Driscoll","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2007.12.007_bib2","series-title":"Severe infections caused by Pseudomonas aeruginosa","author":"Hauser","year":"2003"},{"key":"10.1016\/j.vaccine.2007.12.007_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.burns.2003.11.010","article-title":"Aerobic bacterial isolates from burn wound infections and their antibiograms: five-year study","volume":"30","author":"Agnihotri","year":"2004","journal-title":"Burns"},{"key":"10.1016\/j.vaccine.2007.12.007_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.burns.2003.12.013","article-title":"Changes of microbial flora and wound colonization in burned patients","volume":"30","author":"Erol","year":"2004","journal-title":"Burns"},{"key":"10.1016\/j.vaccine.2007.12.007_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jac\/17.4.505","article-title":"An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre","volume":"17","author":"Pedersen","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2007.12.007_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(96)05169-0","article-title":"Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic","volume":"348","author":"Cheng","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.12.007_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000087686","article-title":"Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa","volume":"73","author":"Lechtzin","year":"2006","journal-title":"Respiration"},{"key":"10.1016\/j.vaccine.2007.12.007_bib8","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1128\/JB.187.14.4908-4920.2005","article-title":"A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance","volume":"187","author":"Salunkhe","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/thorax.57.6.559","article-title":"Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives","volume":"57","author":"McCallum","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2007.12.007_bib10","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.1073\/pnas.0702403104","article-title":"A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients","volume":"104","author":"D\u00f6ring","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.12.007_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.inf.0000129688.50588.ac","article-title":"Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection","volume":"23","author":"Lang","year":"2004","journal-title":"Pediat Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.12.007_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients","volume":"109","author":"Worlitzsch","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2007.12.007_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2958.2005.04552.x","article-title":"Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis","volume":"56","author":"Ramsey","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib14","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0008-6215(03)00312-4","article-title":"Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen","volume":"338","author":"Pier","year":"2003","journal-title":"Carbohyd Res"},{"key":"10.1016\/j.vaccine.2007.12.007_bib15","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1517\/14712598.5.7.967","article-title":"Pseudomonas aeruginosa: the potential to immunise against infection","volume":"5","author":"Sedlak-Weinstein","year":"2005","journal-title":"Exp Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2007.12.007_bib16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.vaccine.2003.11.028","article-title":"Pseudomonas immunotherapy: a historical overview","volume":"22","author":"Holder","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4052\/tigg.14.53","article-title":"Lipopolysaccharide: structure, bioactivity, receptors, and signal transduction","volume":"14","author":"Ulmer","year":"2002","journal-title":"Trends Glycosci Glycotechnol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib18","first-page":"209","article-title":"Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine","volume":"229","author":"Hanessian","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.12.007_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9343(75)90498-2","article-title":"Use of a Pseudomonas aeruginosa vaccine in patients with acute leukemia and cystic fibrosis","volume":"58","author":"Pennington","year":"1975","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2007.12.007_bib20","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1128\/IAI.68.11.6202-6208.2000","article-title":"Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine","volume":"68","author":"Bennett-Guerrero","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/09680519020080010401","article-title":"The biological activity of a liposomal complete core lipopolysaccharide vaccine","volume":"8","author":"Erridge","year":"2002","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.vaccine.2007.12.007_bib22","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1128\/IAI.62.9.3972-3979.1994","article-title":"Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine","volume":"62","author":"Pier","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0008-6215(00)90036-3","article-title":"Monomer sequence and acetylation pattern in some bacterial alginates","volume":"154","author":"Skjak-Braek","year":"1986","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2007.12.007_bib24","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1128\/IAI.62.9.3608-3616.1994","article-title":"Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa","volume":"62","author":"Hatano","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1128\/IAI.59.1.45-50.1991","article-title":"Synthesis and characterization of a Pseudomonas aeruginosa alginate\u2013toxin A conjugate vaccine","volume":"59","author":"Cryz","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib26","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1128\/IAI.71.7.3875-3884.2003","article-title":"Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide\u2013alginate conjugate vaccine","volume":"71","author":"Theilacker","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1099\/jmm.0.46696-0","article-title":"Synthesis and characterization of Pseudomonas aeruginosa alginate\u2013tetanus toxoid conjugate","volume":"55","author":"Kashef","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000417618","article-title":"Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humans","volume":"42","author":"Cryz","year":"1989","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.vaccine.2007.12.007_bib29","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1016\/j.vaccine.2006.03.007","article-title":"Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa","volume":"24","author":"Zuercher","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib30","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/infdis\/169.5.1159","article-title":"Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa","volume":"169","author":"Cryz","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.12.007_bib31","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/0140-6736(91)92103-9","article-title":"Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis","volume":"338","author":"Schaad","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.12.007_bib32","series-title":"Cystic fibrosis","first-page":"69","article-title":"Immunology of cystic fibrosis","author":"D\u00f6ring","year":"2007"},{"key":"10.1016\/j.vaccine.2007.12.007_bib33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-79-4-518","article-title":"Pseudomonas aeruginosa vaccine in cancer patients","volume":"79","author":"Young","year":"1973","journal-title":"Ann Intern Med"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2007.12.007_bib34","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/infdis\/130.Supplement.S152","article-title":"Immunisation against Pseudomonas aeruginosa in infection after thermal injury","volume":"130","author":"Alexander","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.12.007_bib35","first-page":"607","article-title":"Prevention of Pseudomonas respiratory infection in a surgical intensive care unit","volume":"177","author":"Polk","year":"1973","journal-title":"Ann Surg"},{"key":"10.1016\/j.vaccine.2007.12.007_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1099\/00222615-10-1-19","article-title":"A new polyvalent Pseudomonas aeruginosa vaccine","volume":"10","author":"Miller","year":"1977","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/IAI.51.2.675-686.1986","article-title":"Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV","volume":"51","author":"MacIntyre","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/adc.59.12.1131","article-title":"Prospective, controlled study of a polyvalent Pseudomonas vaccine in cystic fibrosis\u2014three year results","volume":"59","author":"Langford","year":"1984","journal-title":"Arch Dis Child"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2007.12.007_bib39","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.vaccine.2004.08.016","article-title":"Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients","volume":"22","author":"Lang","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1574-695X.2006.00103.x","article-title":"Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis","volume":"47","author":"Zuercher","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2249.2005.02964.x","article-title":"Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine","volume":"143","author":"Zuercher","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/IAI.42.1.170-177.1983","article-title":"Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains","volume":"42","author":"Hancock","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib43","first-page":"228","article-title":"Flagella specific H antigenic schema of Pseudomonas aeruginosa","volume":"242","author":"Ansorg","year":"1978","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg I Abt Orig A"},{"key":"10.1016\/j.vaccine.2007.12.007_bib44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/IAI.49.3.770-774.1985","article-title":"Electrophoretic separation and molecular weight characterization of Pseudomonas aeruginosa H-antigen flagellins","volume":"49","author":"Allison","year":"1985","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-5793(96)01099-X","article-title":"Genetic diversity of flagellins of Pseudomonas aeruginosa","volume":"396","author":"Spangenberg","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2007.12.007_bib46","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1165\/rcmb.2006-0022SF","article-title":"Flagellar activation of epithelial signaling","volume":"34","author":"Prince","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2958.2003.03740.x","article-title":"A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa","volume":"50","author":"Dasgupta","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib48","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/IAI.55.3.600-603.1987","article-title":"Pseudomonas aeruginosa adhesins for tracheobronchial mucin","volume":"55","author":"Ramphal","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1165\/rcmb.2003-0260OC","article-title":"Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5","volume":"30","author":"Adamo","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib50","doi-asserted-by":"crossref","first-page":"12487","DOI":"10.1073\/pnas.0605200103","article-title":"Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria","volume":"103","author":"Feuillet","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.12.007_bib51","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1128\/JB.00636-06","article-title":"The AlgT-dependent transcriptional regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile Pseudomonas aeruginosa cystic fibrosis isolates","volume":"188","author":"Tart","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005373-198602000-00003","article-title":"Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations","volume":"26","author":"Holder","year":"1986","journal-title":"J Trauma"},{"key":"10.1016\/j.vaccine.2007.12.007_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/IAI.66.1.43-51.1998","article-title":"Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection","volume":"66","author":"Feldman","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib54","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/02713689209000747","article-title":"Systemic and topical protection studies using Pseudomonas aeruginosa flagella in an ocular model of infection","volume":"11","author":"Rudner","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.vaccine.2007.12.007_bib55","first-page":"43","article-title":"The first clinical trial of Immuno's experimental Pseudomonas aeruginosa flagellar vaccines","volume":"44","author":"Crowe","year":"1991","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.vaccine.2007.12.007_bib56","first-page":"983","article-title":"Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals","volume":"151","author":"D\u00f6ring","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2007.12.007_bib57","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.12.007_bib58","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(85)92222-6","article-title":"Nebulised colomycin for early Pseudomonas aeruginosa colonisation in cystic fibrosis","volume":"i","author":"Littlewood","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.12.007_bib59","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0140-6736(91)91446-2","article-title":"Prevention of chronic Pseudomonas aeruginosa colonisation by early treatment","volume":"338","author":"Valerius","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.12.007_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/(SICI)1099-0496(199802)25:2<88::AID-PPUL3>3.0.CO;2-J","article-title":"Placebocontrolled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis","volume":"25","author":"Wiesemann","year":"1998","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib61","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ppul.1121","article-title":"Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization","volume":"32","author":"Munck","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib62","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(02)07726-7","article-title":"Early Pseudomonas aeruginosa colonization in cystic fibrosis patients","volume":"359","author":"Taccetti","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.12.007_bib63","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(01)06124-4","article-title":"Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis","volume":"358","author":"Ratjen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.12.007_bib64","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1164\/rccm.200208-855OC","article-title":"Cystic Fibrosis Therapeutics Development Network Study Group. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis","volume":"167","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2007.12.007_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09031936.05.00009605","article-title":"Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients","volume":"26","author":"Taccetti","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2007.12.007_bib66","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0092-8674(00)81724-9","article-title":"Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease","volume":"95","author":"Matsui","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2007.12.007_bib67","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4049\/jimmunol.175.2.1090","article-title":"Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces","volume":"175","author":"Matsui","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib68","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/infdis\/146.6.770","article-title":"Outer membrane proteins of P. aeruginosa serotype strains","volume":"146","author":"Mutharia","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.12.007_bib69","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1128\/jb.171.8.4130-4137.1989","article-title":"Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning sequence, and expression in Escherichia coli","volume":"171","author":"Duchene","year":"1989","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib70","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/IAI.63.5.1855-1862.1995","article-title":"Protection of immunocompromised mice against lethal infection with P. aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins","volume":"63","author":"von Specht","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib71","first-page":"1001","article-title":"General pharmacology of a Pseudomonas vaccine prepared from outer-membrane fractions of Pseudomonas aeruginosa","volume":"46","author":"Park","year":"1996","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.vaccine.2007.12.007_bib72","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1126\/science.8456293","article-title":"Naked DNA points way to vaccines","volume":"259","author":"Cohen","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2007.12.007_bib73","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib74","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/IAI.66.8.3990-3994.1998","article-title":"A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection","volume":"66","author":"Staczek","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib75","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1128\/IAI.72.11.6546-6553.2004","article-title":"Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF\u2013OprI from Pseudomonas aeruginosa","volume":"72","author":"Arnold","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1099\/00222615-38-2-79","article-title":"Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model","volume":"38","author":"Gilleland","year":"1993","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib77","first-page":"326","article-title":"The Pseudomonas aeruginosa outer membrane protein I vaccine: immunogenicity and safe administration in man","volume":"98","author":"von Specht","year":"1997","journal-title":"Behring Inst Mitteil"},{"key":"10.1016\/j.vaccine.2007.12.007_bib78","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0264-410X(98)00420-4","article-title":"A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa","volume":"17","author":"Knapp","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib79","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s002530051555","article-title":"Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection","volume":"52","author":"Chen","year":"1999","journal-title":"Appl Microbiol Biotech"},{"key":"10.1016\/j.vaccine.2007.12.007_bib80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0928-8244(03)00073-7","article-title":"Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa","volume":"37","author":"Thomas","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib81","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1128\/IAI.67.3.1461-1470.1999","article-title":"Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F\u2013I vaccine in human volunteers","volume":"67","author":"Mansouri","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib82","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0264-410X(00)00550-8","article-title":"Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F\u2013I vaccine in human volunteers","volume":"19","author":"Larbig","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib83","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.vaccine.2003.11.029","article-title":"Recombinant OprF\u2013OprI as a vaccine against Pseudomonas aeruginosa infections","volume":"22","author":"Baumann","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib84","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jlb.61.5.575","article-title":"Neutrophils from burn patients are unable to increase the expression of CD11b\/CD18 in response to inflammatory stimuli","volume":"61","author":"Rodeberg","year":"1997","journal-title":"J Leukocytol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib85","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0928-8244(03)00072-5","article-title":"Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF\u2013OprI vaccine in burn patients","volume":"37","author":"Mansouri","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib86","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0928-8244(03)00094-4","article-title":"Mucosal vaccination with a recombinant OprF\u2013I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule","volume":"37","author":"Gocke","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.12.007_bib87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1465-9921-8-57","article-title":"Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I\/II study","volume":"5","author":"Baumann","year":"2007","journal-title":"Respir Res"},{"key":"10.1016\/j.vaccine.2007.12.007_bib88","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0264-410X(98)00159-5","article-title":"Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine","volume":"17","author":"Jang","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib89","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0264-410X(00)00235-8","article-title":"Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients","volume":"19","author":"Kim","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib90","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/S0264-410X(99)00479-X","article-title":"Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy","volume":"18","author":"Lee","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib91","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/IAI.74.2.968-974.2006","article-title":"Safety and immunogenicity of an oral inactivated whole-cell Pseudomonas aeruginosa vaccine administered to healthy human subjects","volume":"74","author":"Cripps","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib92","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1128\/IAI.70.3.1507-1517.2002","article-title":"Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine","volume":"70","author":"Priebe","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib93","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0264-410X(88)80017-3","article-title":"Auxotrophic Salmonella typhi as live vaccine","volume":"6","author":"Stocker","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib94","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1128\/IAI.72.12.7012-7021.2004","article-title":"Oral vaccination of BALB\/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model","volume":"72","author":"DiGiandomenico","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib95","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.71.3.1453-1461.2003","article-title":"Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant","volume":"71","author":"Priebe","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib96","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/IAI.74.2.975-983.2006","article-title":"A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection","volume":"74","author":"Zaidi","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib97","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1073\/pnas.0608657104","article-title":"Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections","volume":"104","author":"DiGiandomenico","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2007.12.007_bib98","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000094054","article-title":"Type IV pilin structures: insights on shared architecture, fiber assembly, receptor binding and type II secretion","volume":"11","author":"Hansen","year":"2006","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib99","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1099\/mic.0.26822-0","article-title":"Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients","volume":"150","author":"Kus","year":"2004","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2007.12.007_bib100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1006\/jmbi.2000.3801","article-title":"Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding","volume":"299","author":"Hazes","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib101","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1021\/bi048957s","article-title":"Crystallographic analysis of the Pseudomonas aeruginosa strain K122-4 monomeric pilin reveals a conserved receptor-binding architecture","volume":"43","author":"Audett","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2007.12.007_bib102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-695X.2006.00069.x","article-title":"Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice","volume":"47","author":"Ohama","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib103","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1128\/IAI.69.11.6962-6969.2001","article-title":"Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein","volume":"69","author":"Hertle","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib104","first-page":"141","article-title":"Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein","volume":"1","author":"Sheth","year":"1995","journal-title":"Biomed Peptides, Proteins Nucleic Acids"},{"key":"10.1016\/j.vaccine.2007.12.007_bib105","doi-asserted-by":"crossref","first-page":"11334","DOI":"10.1021\/bi030102c","article-title":"Interaction of a peptide from the receptor-binding domain of Pseudomonas aeruginosa pili strain PAK with a cross-reactive antibody: changes in backbone dynamics induced by binding","volume":"42","author":"Campbell","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2007.12.007_bib106","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0264-410X(00)00362-5","article-title":"Expression and testing of Pseudomonas aeruginosa vaccine candidate proteins prepared with the Caulobacter crescentus S-layer protein expression system","volume":"19","author":"Umelo-Njaka","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib107","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1128\/JB.00273-06","article-title":"Pseudomonas aeruginosa 1244 pilin glycosylation: glycan substrate recognition","volume":"188","author":"Horzempa","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib108","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/7391","article-title":"Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury","volume":"5","author":"Sawa","year":"1999","journal-title":"Nature Med"},{"key":"10.1016\/j.vaccine.2007.12.007_bib109","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1128\/IAI.69.9.5908-5910.2001","article-title":"PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice","volume":"69","author":"Holder","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/smim.1997.0083","article-title":"DNA vaccines","volume":"9","author":"Robinson","year":"1997","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib111","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm1096-1122","article-title":"DNA-based immunization by in vivo transfection of dendritic cells","volume":"2","author":"Condon","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.12.007_bib112","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/14760584.6.2.227","article-title":"Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells","volume":"6","author":"Tsen","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.12.007_bib113","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.188.6.1075","article-title":"Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization","volume":"188","author":"Porgador","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.12.007_bib114","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1128\/IAI.69.5.3510-3515.2001","article-title":"Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib115","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/j.vaccine.2006.05.077","article-title":"Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa","volume":"24","author":"Saha","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib116","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI200523135","article-title":"Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid","volume":"115","author":"Worgall","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2007.12.007_bib117","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1574-695X.2000.tb01425.x","article-title":"Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A","volume":"27","author":"Denis-Mize","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib118","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-695X.2002.tb00577.x","article-title":"Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa","volume":"33","author":"Price","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib119","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0928-8244(03)00075-0","article-title":"DNA vaccines against chronic lung infections by Pseudomonas aeruginosa","volume":"37","author":"Staczek","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM198709243171303","article-title":"Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis","volume":"317","author":"Pier","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.12.007_bib121","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/IAI.67.9.4744-4750.1999","article-title":"Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype","volume":"67","author":"Parad","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib122","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0002-9343(84)90337-1","article-title":"Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa","volume":"76","author":"Collins","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2007.12.007_bib123","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/infdis\/174.3.537","article-title":"Immunoprophylaxis against Klebsiella and Pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group","volume":"174","author":"Donta","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.12.007_bib124","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/IAI.69.4.2223-2229.2001","article-title":"Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis","volume":"69","author":"Hemachandra","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib125","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1016\/j.vaccine.2005.01.088","article-title":"Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes","volume":"23","author":"Lai","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.007_bib126","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.00366-07","article-title":"A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro","volume":"51","author":"McLean","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2007.12.007_bib127","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3233\/HAB-1990-1204","article-title":"Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization","volume":"1","author":"Lang","year":"1990","journal-title":"Hum Antibod Hybridom"},{"key":"10.1016\/j.vaccine.2007.12.007_bib128","first-page":"121","article-title":"Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides","volume":"71","author":"Lang","year":"1990","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2007.12.007_bib129","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.4049\/jimmunol.173.9.5671","article-title":"Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains","volume":"173","author":"Pier","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/431516","article-title":"Non-mucoid Pseudomonas aeruginosa expresses alginate in lungs of patients with cystic fibrosis and in a murine model","volume":"192","author":"Bragonzi","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.12.007_bib131","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1139\/m87-130","article-title":"Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagella serum","volume":"33","author":"Drake","year":"1987","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib132","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.36.6.1290","article-title":"Effects of a human antiflagellar monoclonal antibody in combination with antibiotics on Pseudomonas aeruginosa infection","volume":"36","author":"Uezumi","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2007.12.007_bib133","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/IAI.59.2.550-554.1991","article-title":"Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa","volume":"59","author":"Ochi","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib134","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1128\/IAI.58.12.3819-3828.1990","article-title":"Generation and characterization of murine antiflagellum monoclonal antibodies that are protective against lethal challenge with Pseudomonas aeruginosa","volume":"58","author":"Rosok","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib135","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/CDLI.6.4.537-541.1999","article-title":"Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice","volume":"6","author":"Matsumoto","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib136","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1128\/IAI.62.11.4825-4830.1994","article-title":"Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat","volume":"62","author":"Landsperger","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.12.007_bib137","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/AAC.37.2.164","article-title":"Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia","volume":"37","author":"Oishi","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2007.12.007_bib138","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.4049\/jimmunol.167.10.5880","article-title":"Therapeutic administration of anti-PcrV F(ab\u2019)(2) in sepsis associated with Pseudomonas aeruginosa","volume":"167","author":"Shime","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.12.007_bib139","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.burns.2004.09.002","article-title":"Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge","volume":"31","author":"Neely","year":"2005","journal-title":"Burns"},{"key":"10.1016\/j.vaccine.2007.12.007_bib140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/341069","article-title":"Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV","volume":"186","author":"Frank","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.12.007_bib141","article-title":"Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model","volume":"1","author":"Faure","year":"2003","journal-title":"J Immune Ther Vaccines"},{"key":"10.1016\/j.vaccine.2007.12.007_bib142","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00005373-198802000-00003","article-title":"A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients","volume":"28","author":"Hunt","year":"1998","journal-title":"J Trauma"},{"key":"10.1016\/j.vaccine.2007.12.007_bib143","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(80)92334-X","article-title":"Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients","volume":"2","author":"Jones","year":"1980","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07014570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07014570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T12:43:23Z","timestamp":1588337003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07014570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":143,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0264410X07014570"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.12.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}